Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma
- PMID:7605996
Heterogeneous expression of Epstein-Barr virus latent proteins in endemic Burkitt's lymphoma
Abstract
Epstein-Barr virus (EBV)-infected cells may sustain three distinct forms of virus latency. In lymphoblastoid cell lines, six EBV-encoded nuclear antigens (EBNA1, 2, 3A, 3B, 3C, -LP), three latent membrane proteins (LMP1, 2A, 2B), and two nuclear RNAs (EBERs) are expressed. This form of latency, termed latency III, is also encountered in some posttransplant lymphoproliferative disorders. In EBV-positive cases of Hodgkin's disease, the EBERs, EBNA1, and the LMPs are expressed (latency II), whereas in Burkitt's lymphoma (BL) only the EBERs and EBNA1 have been detected (latency I). We have studied the expression of EBV proteins in 17 cases of EBV-positive endemic BL by immunohistology. Expression of LMP1 was seen in variable proportions of tumor cells in two cases and EBNA2 was detected in some tumor cells in three other cases. Also, the BZLF1 trans-activator protein was expressed in a few tumor cells in 6 cases, indicating entry into the lytic cycle. A phenotypic drift from latency I to latency III has been observed previously in some BL cell lines. Our results suggest that a similar phenomenon may occur in BL in vivo and indicate that the operational definition of EBV latencies is not easily applied to human tumors.
Similar articles
- Expression of Epstein-Barr virus-gene products in Burkitt's lymphoma in Northeast Brazil.Araujo I, Foss HD, Bittencourt A, Hummel M, Demel G, Mendonca N, Herbst H, Stein H.Araujo I, et al.Blood. 1996 Jun 15;87(12):5279-86.Blood. 1996.PMID:8652843
- Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8.Horenstein MG, Nador RG, Chadburn A, Hyjek EM, Inghirami G, Knowles DM, Cesarman E.Horenstein MG, et al.Blood. 1997 Aug 1;90(3):1186-91.Blood. 1997.PMID:9242551
- Expression of Epstein-Barr virus-encoded latent membrane protein 1 in nonendemic Burkitt's lymphomas.Carbone A, Gloghini A, Zagonel V, Tirelli U.Carbone A, et al.Blood. 1996 Feb 1;87(3):1202-4.Blood. 1996.PMID:8562951No abstract available.
- EBV-NK cells interactions and lymphoproliferative disorders.Kanegane H, Yachie A, Miyawaki T, Tosato G.Kanegane H, et al.Leuk Lymphoma. 1998 May;29(5-6):491-8. doi: 10.3109/10428199809050908.Leuk Lymphoma. 1998.PMID:9643562Review.
- EBNA2 and Its Coactivator EBNA-LP.Kempkes B, Ling PD.Kempkes B, et al.Curr Top Microbiol Immunol. 2015;391:35-59. doi: 10.1007/978-3-319-22834-1_2.Curr Top Microbiol Immunol. 2015.PMID:26428371Review.
Cited by
- Lymphomas differ in their dependence on Epstein-Barr virus.Vereide DT, Sugden B.Vereide DT, et al.Blood. 2011 Feb 10;117(6):1977-85. doi: 10.1182/blood-2010-05-285791. Epub 2010 Nov 18.Blood. 2011.PMID:21088132Free PMC article.
- Molecular signature of Epstein-Barr virus infection in MS brain lesions.Moreno MA, Or-Geva N, Aftab BT, Khanna R, Croze E, Steinman L, Han MH.Moreno MA, et al.Neurol Neuroimmunol Neuroinflamm. 2018 Jun 7;5(4):e466. doi: 10.1212/NXI.0000000000000466. eCollection 2018 Jul.Neurol Neuroimmunol Neuroinflamm. 2018.PMID:29892607Free PMC article.
- Epstein-Barr virus perpetuates B cell germinal center dynamics and generation of autoimmune-associated phenotypesin vitro.SoRelle ED, Reinoso-Vizcaino NM, Horn GQ, Luftig MA.SoRelle ED, et al.Front Immunol. 2022 Sep 28;13:1001145. doi: 10.3389/fimmu.2022.1001145. eCollection 2022.Front Immunol. 2022.PMID:36248899Free PMC article.
- Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.Brink AA, Meijer CJ, Nicholls JM, Middeldorp JM, van den Brule AJ.Brink AA, et al.Mol Pathol. 2001 Apr;54(2):98-102. doi: 10.1136/mp.54.2.98.Mol Pathol. 2001.PMID:11322171Free PMC article.
- Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB.Kelly GL, et al.Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40. doi: 10.1073/pnas.0509988103. Epub 2006 Sep 25.Proc Natl Acad Sci U S A. 2006.PMID:17001014Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources